Medicare Enrolled

Dr. Lorenzo Aguilar, MD

Neurology · Modesto, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
600 COFFEE RD, Modesto, CA 95355
2095504785
In practice since 2007 (18 years)
NPI: 1740481043 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Aguilar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aguilar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Aguilar

Dr. Lorenzo Aguilar is a neurology specialist in Modesto, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Aguilar performed 514 Medicare services across 463 unique beneficiaries.

Between the years covered by Open Payments, Dr. Aguilar received a total of $27,884 from 87 pharmaceutical and/or device companies across 1217 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Aguilar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 48% volume in CA $27,884 industry payments

Medicare Practice Summary

Medicare Utilization ↗
514
Medicare services
Top 48% in CA for neurology
463
Unique beneficiaries
$200
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~29 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
165 $350 $827
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
145 $92 $150
New patient office visit, complex (60-74 min) 114 $172 $290
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
47 $217 $800
Additional 30 minutes of psychological or neuropsychological testing
This code represents an additional 30-minute increment for administering psychological or neuropsychological tests. It is used to bill for time beyond the initial testing period.
16 $28 $150
Psychological or neuropsychological test, first 30 minutes
Administration of psychological or neuropsychological testing for the first 30 minutes.
15 $33 $150
Neuropsychological test evaluation, first hour
A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process.
12 $104 $270
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$27,884
Total received (2018-2024)
Avg $3,983/year across 7 years
Top 12% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
87
Companies
1,217
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,801 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$84 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,403
2023
$3,443
2022
$4,301
2021
$5,799
2020
$2,084
2019
$5,535
2018
$3,319

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$1,025
UCB, Inc.
$430
Eisai Inc.
$209
ABBVIE INC.
$175
Novartis Pharmaceuticals Corporation
$165
Biogen, Inc.
$139
SK Life Science, Inc.
$134
LivaNova USA, Inc.
$112
Alexion Pharmaceuticals, Inc.
$109
Lilly USA, LLC
$98
EMD Serono, Inc.
$85
Averitas Pharma Inc.
$81
Sumitomo Pharma America, Inc.
$63
JAZZ PHARMACEUTICALS INC.
$53
PFIZER INC.
$52
Amneal Pharmaceuticals LLC
$48
Teva Pharmaceuticals USA, Inc.
$46
ACADIA Pharmaceuticals Inc
$45
HOSPIRA, INC.
$44
Genentech USA, Inc.
$42
GE HEALTHCARE
$38
Celgene Corporation
$35
Neurocrine Biosciences, Inc.
$31
MDD US Operations, LLC
$31
Octapharma USA, Inc.
$29
Baxter Healthcare
$29
SCILEX PHARMACEUTICALS INC.
$20
Otsuka America Pharmaceutical, Inc.
$19
MITSUBISHI TANABE PHARMA AMERICA, INC.
$16
Top 3 companies account for 48.9% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$2,273
LivaNova USA, Inc.
$1,588
Biohaven Pharmaceutical Holding Company Ltd.
$1,320
Abbott Laboratories
$1,234
EMD Serono, Inc.
$1,137
Medtronic, Inc.
$1,025
NEUROPACE, INC.
$1,019
Teva Pharmaceuticals USA, Inc.
$1,002
BOSTON SCIENTIFIC CORPORATION
$922
AbbVie Inc.
$920
Biogen, Inc.
$839
Novartis Pharmaceuticals Corporation
$809
Amneal Pharmaceuticals LLC
$702
Allergan, Inc.
$651
Janssen Pharmaceuticals, Inc
$619
PFIZER INC.
$613
GENZYME CORPORATION
$565
Lilly USA, LLC
$557
Eisai Inc.
$511
NOVARTIS PHARMACEUTICALS CORPORATION
$485
Adamas Pharmaceuticals, Inc.
$416
Genentech USA, Inc.
$411
ACADIA Pharmaceuticals Inc
$383
ABBVIE INC.
$350
SK Life Science, Inc.
$341
Celgene Corporation
$340
Neurelis, Inc.
$326
Lundbeck LLC
$304
Greenwich Biosciences, Inc.
$297
Supernus Pharmaceuticals, Inc.
$264
Akcea Therapeutics, Inc.
$241
Alexion Pharmaceuticals, Inc.
$240
Alnylam Pharmaceuticals Inc.
$233
BANNER LIFE SCIENCES, LLC
$224
Neurocrine Biosciences, Inc.
$205
Amgen Inc.
$196
CSL Behring
$189
MDD US Operations, LLC
$186
AQUESTIVE THERAPEUTICS, INC.
$183
Sumitomo Pharma America, Inc.
$173
US WorldMeds, LLC
$165
Biohaven Pharmaceuticals, Inc.
$164
Grifols USA, LLC
$148
AstraZeneca Pharmaceuticals LP
$144
Mitsubishi Tanabe Pharma America, Inc.
$137
Mallinckrodt Hospital Products Inc.
$132
Takeda Pharmaceuticals U.S.A., Inc.
$131
Avanir Pharmaceuticals, Inc.
$131
SANOFI-AVENTIS U.S. LLC
$131
Allergan Inc.
$130
HOSPIRA, INC.
$128
Mallinckrodt Enterprises LLC
$127
CATALYST PHARMACEUTICALS, INC.
$125
GE HEALTHCARE
$125
JAZZ PHARMACEUTICALS INC.
$114
Acorda Therapeutics, Inc
$107
Banner Life Sciences, LLC
$99
Averitas Pharma Inc.
$99
MITSUBISHI TANABE PHARMA AMERICA, INC.
$91
Kyowa Kirin, Inc.
$81
UPSHER-SMITH LABORATORIES LLC
$80
Zogenix Inc.
$73
Octapharma USA, Inc.
$72
EISAI INC.
$70
Scilex Pharmaceuticals Inc.
$69
Otsuka America Pharmaceutical, Inc.
$63
Merz North America, Inc.
$62
ARGENX US, INC.
$59
Catalyst Pharmaceuticals, Inc.
$54
Impax Laboratories, Inc.
$53
Jazz Pharmaceuticals Inc.
$49
Almatica Pharma LLC
$49
Piramal Imaging Limited
$43
SCILEX PHARMACEUTICALS INC.
$38
Boston Scientific Corporation
$32
Baxter Healthcare
$29
Otsuka Pharmaceutical Development & Commercialization, Inc.
$25
IDORSIA PHARMACEUTICALS US INC
$20
NeuroPace, Inc.
$19
Sobi, Inc
$19
MERZ NORTH AMERICA, INC.
$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
Medtronic USA, Inc.
$16
E.R. Squibb & Sons, L.L.C.
$15
GRT US Holding, Inc.
$14
Arbor Pharmaceuticals, Inc.
$14
Mallinckrodt LLC
$13
Top 3 companies account for 18.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Banzel · Briviact · COMIRNATY · DUOPA · ELIQUIS · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GENERAL DBS · GENERAL - DBS · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gocovri · Hillrom - Monarch Airway Clearance System · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KINERET · KISUNLA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · PANZYGA · PAXLOVID · PERCEPT PC BRAINSENSE · Ponvory · Proclaim Family of SCS IPGs · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RADICAVA · RELISTOR · REXULTI · REYVOW · RNS Neurostimulator Kit · RNS System · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SUBOXONE · SYMPAZAN · Soliris · TECFIDERA · TEGSEDI · TOSYMRA · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · UBRELVY · ULTOMIRIS · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VYALEV · VYEPTI · VYVGART · Vimpat · XARELTO · XCOPRI · XEOMIN · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Modesto?
Compare neurologists in the Modesto area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
19
Per 100K population
3.4
County median income
$79,661
Nearest hospital
MEMORIAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Aguilar is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 12% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Aguilar experienced with eeg, extended monitoring?
Based on Medicare claims data, Dr. Aguilar performed 165 eeg, extended monitoring services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aguilar receive payments from pharmaceutical companies?
Yes. Dr. Aguilar received a total of $27,884 from 87 companies across 1,217 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aguilar's costs compare to other neurologists in Modesto?
Dr. Aguilar's average Medicare payment per service is $200. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aguilar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →